U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07184593) titled 'Nucleosome Monitoring Relevance for Outcome Prediction in Critically Ill Patients' on Aug. 26.
Brief Summary: The goal of this observational study is to evaluate whether whole blood H3.1 nucleosome levels can predict 30-day mortality in adult critically ill patients admitted to the ICU with conditions such as sepsis, septic shock, cardiogenic shock, severe trauma, post-cardiac arrest, acute brain injury, or severe acute pancreatitis.
The main questions it aims to answer are:
Do initial whole blood H3.1 nucleosome levels predict 30-day mortality in critically ill patients?
Are whole blood nucleosome measurements using a novel poi...